CytoDyn Inc () CEO Nader Pourhassan tells Proactive that Chiral Pharma Corporation placed its first purchase order for its drug Vyrologix under a compassionate special permit to treat critically ill coronavirus patients in the Philippines.
Pourhassan says the Vancouver, Washington-based late-stage biotech will earn revenue after order fulfillment and the terms of the agreement are ironed out.
A portion of this interview was edited for accuracy.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...
FOR OUR FULL DISCLAIMER CLICK HERE